ACRO BIOMEDICAL CO., LTD. (ACBM) Total liabilities 2017–2025
ACRO BIOMEDICAL CO., LTD. (ACBM) total liabilities at each fiscal year-end, per SEC filings.
$401,062FY2025 · since FY2017: $36,979 → $401,062
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $401,062 | +22.7% |
| FY2024 | $326,946 | +3.6% |
| FY2023 | $315,473 | +56.9% |
| FY2022 | $201,116 | +71.4% |
| FY2021 | $117,370 | -62.4% |
| FY2020 | $312,185 | +133.2% |
| FY2019 | $133,887 | -44.4% |
| FY2018 | $240,675 | +550.8% |
| FY2017 | $36,979 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice